Technologies related to NEI

Custom text
Treatment of Oculocutaneous/Ocular Albinism and for Increasing Pigmentation
Ref: E-113-2010 | Updated: 06/21/2021
Treatment of Oculocutaneous/Ocular Albinism and for Increasing Pigmentation
Ref: NCI-E-113-2010 | Updated: 06/21/2021
Ex-vivo Production of Regulatory B-Cells for Use in Auto-immune Diseases
Ref: NCI-E-036-2012 | Updated: 06/04/2021
Ex-vivo Production of Regulatory B-Cells for Use in Auto-immune Diseases
Ref: E-036-2012 | Updated: 06/04/2021
Gene Therapy for Treatment of CRX-Autosomal Dominant Retinopathies
Ref: E-008-2020 | Updated: 06/04/2021
Gene Therapy for Treatment of CRX-Autosomal Dominant Retinopathies
Ref: NCI-E-008-2020 | Updated: 06/04/2021
Mouse Embryo Culture Chamber and Imaging System and Methods of Use
Ref: E-042-2020 | Updated: 06/04/2021
Mouse Embryo Culture Chamber and Imaging System and Methods of Use
Ref: NCI-E-042-2020 | Updated: 06/04/2021
Induced Pluripotent Stem Cells Derived from Patients with CEP290-associated Ciliopathies and Unaffected Family Members
Ref: E-100-2020 | Updated: 06/04/2021
Induced Pluripotent Stem Cells Derived from Patients with CEP290-associated Ciliopathies and Unaffected Family Members
Ref: NCI-E-100-2020 | Updated: 06/04/2021
Use of Interleukin (IL)-34 to Treat Retinal Inflammation and Neurodegeneration
Ref: E-091-2018 | Updated: 06/04/2021
Use of Interleukin (IL)-34 to Treat Retinal Inflammation and Neurodegeneration
Ref: NCI-E-091-2018 | Updated: 06/04/2021
Metformin for the Treatment of Age-related Retinal Degeneration
Ref: E-227-2018 | Updated: 06/04/2021
Metformin for the Treatment of Age-related Retinal Degeneration
Ref: NCI-E-227-2018 | Updated: 06/04/2021
Strategies to Protect Mammalian Neural Tissue Against Cold and Potentially Other Metabolic Stresses and Physical Damages
Ref: E-165-2017 | Updated: 06/04/2021
Strategies to Protect Mammalian Neural Tissue Against Cold and Potentially Other Metabolic Stresses and Physical Damages
Ref: NCI-E-165-2017 | Updated: 06/04/2021
3D Vascularized Human Ocular Tissue for Cell Therapy and Drug Discovery
Ref: NCI-E-004-2017 | Updated: 06/04/2021
Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma
Ref: E-044-2018 | Updated: 06/04/2021
3D Vascularized Human Ocular Tissue for Cell Therapy and Drug Discovery
Ref: E-004-2017 | Updated: 06/04/2021
Bone Marrow Mesenchymal Stem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma
Ref: NCI-E-044-2018 | Updated: 06/04/2021
Method for Reproducible Differentiation of Clinical Grade Retinal Pigment Epithelium Cells
Ref: E-212-2015 | Updated: 06/04/2021
Machine Learning and/or Neural Networks to Validate Stem Cells and Their Derivatives for Use in Cell Therapy, Drug Delivery, and Diagnostics
Ref: E-058-2018 | Updated: 06/04/2021
Method for Reproducible Differentiation of Clinical Grade Retinal Pigment Epithelium Cells
Ref: NCI-E-212-2015 | Updated: 06/04/2021
Machine Learning and/or Neural Networks to Validate Stem Cells and Their Derivatives for Use in Cell Therapy, Drug Delivery, and Diagnostics
Ref: NCI-E-058-2018 | Updated: 06/04/2021
Methods and Compositions for Treating Genetically Linked Diseases of the Eye
Ref: E-284-2012 | Updated: 06/04/2021
Methods and Compositions for Treating Genetically Linked Diseases of the Eye
Ref: NCI-E-284-2012 | Updated: 06/04/2021
Interleukin 24 (IL-24) to treat inflammatory diseases
Ref: E-119-2017 | Updated: 06/04/2021
Interleukin 24 (IL-24) to treat inflammatory diseases
Ref: NCI-E-119-2017 | Updated: 06/04/2021
Establishment of Induced Pluripotent Stem Cells (iPSC) from the Thirteen-lined Ground Squirrel
Ref: E-059-2017 | Updated: 06/04/2021
Establishment of Induced Pluripotent Stem Cells (iPSC) from the Thirteen-lined Ground Squirrel
Ref: NCI-E-059-2017 | Updated: 06/04/2021
RP2 and RPGR Vectors For Treating X-linked Retinitis Pigmentosa
Ref: E-050-2015 | Updated: 06/04/2021
RP2 and RPGR Vectors For Treating X-linked Retinitis Pigmentosa
Ref: NCI-E-050-2015 | Updated: 06/04/2021
Surgical Tool for Sub-retinal Tissue Implantation
Ref: E-192-2014 | Updated: 06/04/2021
Surgical Tool for Sub-retinal Tissue Implantation
Ref: NCI-E-192-2014 | Updated: 06/04/2021
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
Ref: E-134-2016 | Updated: 06/04/2021
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
Ref: NCI-E-134-2016 | Updated: 06/04/2021
Devices for Improved Tissue Cryopreservation and Recovery
Ref: E-094-2016 | Updated: 06/04/2021
Devices for Improved Tissue Cryopreservation and Recovery
Ref: NCI-E-094-2016 | Updated: 06/04/2021
Tissue Clamp for Repeated Opening and Closure of Incisions/Wounds
Ref: E-293-2016 | Updated: 06/04/2021
Tissue Clamp for Repeated Opening and Closure of Incisions/Wounds
Ref: NCI-E-293-2016 | Updated: 06/04/2021
User-friendly, Powerful Software for Analyzing ChIP-Seq Data
Ref: TAB-2557 | Updated: 06/04/2021
PAPST: Peak Assignment And Profile Search Tool
Ref: E-008-2012-0 | Updated: 06/08/2021
Subscribe to Technologies related to NEI